- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Purpose Bitcoin ETF
Silver47 Exploration
Syntheia
Black Swan Graphene
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Datametrex Provides Additional Information On Its Co-bid To The Ministry Of Health In South Korea Surrounding COVID-19
Datametrex AI Limited (TSXV:DM) provides additional information on a joint venture with Lotte Group announced in the Company’s press release on April 6, 2020.
Datametrex AI Limited (TSXV:DM) (the “Company” or “Datametrex”) would like to provide additional information to our shareholders and the investment community on a joint venture with Lotte Group announced in the Company’s press release on April 6, 2020.
Lotte Group was one of two companies invited to bid on a contract to provide Artificial Intelligence (“AI”) solutions to the South Korean Ministry of Health- Welfare, Food, & Drug, related to the COVID-19 pandemic. Lotte Group has invited Datametrex, a preferred vendor of Lotte, to participate in the bid and to provide the AI technology, should Lotte Group’s bid be successful. The contract is for the implementation of AI solutions to monitor search engine and SNS welfare, food, and drug beneficiaries that will allow the South Korean government to monitor potentially fraudulent activities with COVID-19 related grants. The AI solution required by the South Korean government will also filter incorrect and unreliable information allowing the Ministry of Health and Welfare to gain a better understanding of the COVID-19 pandemic and enable it to maximize efficiency of its human resources.
In the event Lotte Group is awarded the contract, a joint venture will be formed between Lotte Group, Datametrex, and KT Net, a corporation owned and controlled by the South Korean government. If Lotte Group bid is successful, the parties to the proposed joint venture have agreed to establish a joint venture company (“JV Co.”) with Lotte Group owning 75% of the equity in JV Co., Datametrex owning 15% and KT Net owning 10%. Under terms agreed by the parties, Lotte Group would contribute approximately $450,000 to JV Co., Datametrex will provide its proprietary AI technology and KT Net will provide private blockchain technology. The total revenue expected to be earned from this contract is approximately $1.2M annuum, and Datametrex expects to receive its proportionate share of the revenue after payment of JV Co.’s expenses. There is no assurance that Lotte Group will be successful in its bid.
About Lotte Group
The Lotte Group is an international conglomerate consisting of over 90 business units employing 60,000 people engaged in such diverse industries as candy manufacturing, beverages, hotels, fast food, retail, financial services, heavy chemicals, electronics, IT, construction, publishing, and entertainment.
About Datametrex AI Limited
Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Additional information on Datametrex is available at: www.datametrex.com.
For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email: mgunter@datametrex.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.
Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
Click here to connect with Datametrex AI Limited (TSXV:DM, FSE:D4G) for an Investor Presentation
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.